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What is known about this topic? 
• Inflammatory bowel disease (IBD) impacts the quality of life (QoL) in pediatric 
patients.  
• Pediatric IBD patients may have difficulties with school, inability to participate 
in physical activities decreased social competences. 
• Pediatric patients with IBD are at risk for depression, anxiety, social isolation, 
and altered self-image, which can negatively affect health-related quality of life 
(HRQOL) 
 
What this study adds 
• In the KIDSCREEN index only a moderate impairment of children with IBD 
found for physical well-being in the Swiss cohort study.  
• Mental well-being and social support were not different or even better than 
control values, indicating that depression and emotional impairment were not 
more abundant in paediatric IBD patients of this cohort.  
• Autonomy and school variables were significantly higher in the paediatric IBD 
patients in this Swiss cohort.  
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Abstract: 
 
Background: Inflammatory bowel disease (IBD) starting during childhood has been 
assumed to impair quality of life (QoL) of affected children. As this aspect is crucial 
for further personality development, the health-related quality of life (HRQOL) was 
assessed in a Swiss nationwide cohort to obtain detailed information on the fields of 
impairment. 
Methods: Data were prospectively acquired from paediatric patients included in the 
Swiss IBD Cohort Study. IBD activity was evaluated by PCDAI and PUCAI. The age 
adapted KIDSCREEN questionnaire was evaluated for 110 children with IBD (64 with 
Crohn’s disease 46 with ulcerative colitis). Data were analyzed with respect to 
established reference values of healthy controls. 
Results: In the KIDSCREEN index a moderate impairment was only found for 
physical wellbeing due to disease activity. In contrast, mental well-being and social 
support were even better as compared to control values. A subgroup analysis 
revealed that this observation was restricted to the children in the German speaking 
part of Switzerland, whereas there was no difference compared to controls in the 
French part of Switzerland. Furthermore, autonomy and school variables were 
significantly higher in the IBD patients as compared to controls. 
Conclusions: The social support for children with IBD is excellent in this cohort. Only 
physical well-being was impaired due to disease activity, whereas all other 
KIDSCREEN parameters were better as compared to controls. This indicates that 
effective coping and support strategies may be able to compensate the burden of 
disease in paediatric IBD patients. 
 
 
Keywords:  paediatric inflammatory bowel disease; mental well-being; physical well-
being; coping; social support. 
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Introduction 
Inflammatory bowel diseases (IBD), which include Crohn's disease (CD) and 
ulcerative colitis (UC) as well as unclassified IBD, are chronic and sometimes 
disabling diseases with unpredictable courses and difficult treatment. Epidemiological 
studies report high and rising incidence of childhood IBD in Western and Northern 
Europe, in North America and in Asia[1-10]. 
Therapy for IBD has rapidly evolved during recent years with the introduction of novel 
therapies and treatments. Some of these new treatments are expensive and their 
benefit/risk ratio has to be carefully evaluated. On the other hand, the impact of those 
new therapies on patient quality of life (QoL) is often considerable. Paediatric IBD 
patients are affected by a number of problems that are not restricted to the 
gastrointestinal tract[9, 11-13]. When these chronic diseases manifest during 
childhood or adolescence, which is obviously a critical developmental period, the 
transition to adulthood can be impaired by physical but also by psychological 
factors[14]. Paediatric patients with severe IBD, particularly CD, frequently suffer 
from malnutrition, growth failure and pubertal delay at the time of diagnosis[15-18]. 
Furthermore, self-reported difficulties with school absenteeism, inability to participate 
in physical activities [19, 20] and parental-reported decreased social 
competences[21-23] have been reported. 
It is known that - similar to other chronic diseases of childhood and adolescence - 
patients with IBD are at risk for depression, anxiety, social isolation, and altered self-
image, which can negatively affect health-related quality of life (HRQOL)[14, 24-27]. 
Identifying patients with impaired quality of life is of importance, as it may change 
treatment strategies[14, 27]. 
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In 2006 a nationwide cohort study on patients with IBD in Switzerland, the Swiss IBD 
Cohort Study (SIBDCS), was initiated [28]. The general aim of the SIBDCS is to 
provide the Swiss and international scientific, public health and medical community 
information on a disease-oriented prospective cohort of inflammatory bowel disease 
patients. Data from the Swiss IBD cohort (SIBDC) represent up-to date 
epidemiological data (e.g. prevalence, incidence, clinical course of IBD) [28]. In the 
paediatric sub-cohort, the Swiss Paediatric IBD cohort study (SPIBDCS), quality of 
life and psychological adjustment has been evaluated by the KIDSCREEN 
questionnaire. So far it was not clear how this score is associated with characteristics 
of the disease and demographic variables. The purpose of this project was to 
examine medical, individual and demographic determinants of health-related quality 
of life in children and adolescents with IBD. We hypothesized that in a well- 
functioning health system the impact of IBD on HRQoL is limited and coping can 
support an almost normal mental well-being in paediatric IBD patients. 
To challenge our hypothesis the KIDSCREEN results of 110 children in the cohort 
were correlated with medical factors of potential impact such as disease activity 
(PCDAI, PUCAI), surgery, complications, and disease duration. In addition, individual 
factors of the patient (such as age, gender, education, and migratory background) 
were analyzed.  
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Materials and Methods  
Patients 
Since 2006, 2530 adult and pediatric IBD patients from all regions of Switzerland 
have been included into the nationwide Swiss IBD Cohort Study that is supported by 
the Swiss National Science Foundation (SNF) and approved by the local ethics 
committees[28]. Informed consent was obtained from parents and/or patients. At the 
time of inclusion, patients underwent a thorough clinical and laboratory assessment 
including calculation of clinical IBD disease activity scores (including PCDAI and 
PUCAI for paediatric patients). Data acquisition focused on clinical, socio-economic 
and psychosocial data. 110 paediatric patients were available for analysis. Data 
quality was assessed by internal review. 
 
Definitions 
We retrieved data from the registry including demographic items (age and level of 
education at diagnosis, parental age, level of education and economical status at 
diagnosis, siblings and their age and level of education at diagnosis, as well as the 
medical, social and migratory family history), IBD disease factors (disease extension, 
inflammatory activity, complications, current medication, past therapeutic 
interventions, growth and puberty, co-morbidity) as well as data from these activity 
indices:  
The Paediatric Crohn’s Disease Activity Index (PCDAI) is a reliable and valid 8-item 
measure designed to assess disease activity in paediatric patients with CD. It takes 
into account patient history and the following laboratory data: complete blood count 
(CBC), erythrocyte sedimentation rate (ESR), and albumin. Scores range from 0–
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100, with ≤10 indicating inactive disease, 11–30 indicating mild disease, and >30 
indicating moderate-to severe disease[29, 30]. 
The Paediatric Ulcerative Colitis Activity Index (PUCAI) is a validated, non-invasive, 
6-item measure of disease activity with established cut-off values for remission (<10 
points), mild (10–34 points), moderate (35–64 points), and severe disease (65–85 
points). The index takes into account stool frequency, stool consistency, presence of 
bloody stools, nocturnal stools, abdominal pain, and patient activity level[31]. 
  
Questionnaires  
The KIDSCREEN-27 is a Quality of life Questionnaire consisting of 27 items 
measuring physical well-being, psychological well-being, autonomy and parent 
relations, peers and social support, and school environment. The KIDSCREEN-27 
was developed as a shorter version of the KIDSCREEN-52 with good psychometric 
properties[32]. Each of the 27 items is rated as being not true (0), somewhat true (1), 
balanced (2), rather true (3) or certainly true (4). Interscale correlation range from 
0.36 to 0.59 (0.33–0.57) for the self-report (proxy report)[33, 34]. The KIDSCREEN 
has been validatet in a large study involving 3988 children and 2526 child-proxy pairs 
in seven European countries (Austria, Switzerland, Germany, Spain, France, United 
Kingdom, and the Netherlands) [32].  
Sociodemographic information 
Sociodemographic information included age and gender of the child, language of the 
survey (French speaking part of Switzerland versus German speaking part), 
migration status of the child, education, parental education and socioeconomic 
status.  
 
Rogler D. et al.                Excellent HRQoL in Swiss Children with IBD  9 
 
Statistical Analysis  
Clinical data were retrieved from the data centre of the SIBDCS at the University of 
Lausanne. The data were entered into a database (Access 2000, Microsoft 
Switzerland Ltd Liab. Co, 8304 Wallisellen Switzerland). All statistical examinations 
were performed with the STATA statistical software (STATA version 12.1, StataCorp, 
College Station TX, USA). 
Continuous variables distribution was analyzed using Normal-QQ-plots. Gaussian 
continuous variables are presented as the mean ± the standard deviation (SD), while 
non-Gaussian as the median and interquartile range (IQR). Categorical variables are 
given as counts and proportions. Differences between two independent groups with 
regard to Gaussian continuous variables are quantified with the two-sample Student’s 
t-test, or with the Mann–Whitney–Wilcoxon test in case of non-Gaussian distribution. 
Differences between more than two independent groups with regard to Gaussian 
variables are quantified with an analysis of variance (ANOVA), or with the Kruskall-
Wallis test in case of non-Gaussian data. Categorical variables are compared 
between groups using the chi-squared (χ2) test or Fisher’s exact test for small 
samples.  
The strength of association between normally distributed continuous variables was 
measured using Pearson’s correlation coefficient or Spearman’s correlation 
coefficient when the variables presented a non-Gaussian distribution. A p-value < 
0.05 was considered statistically significant. 
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Results 
 
Clinical Characteristics of the Study Population 
143 paediatric patients with IBD have been included into the SIBDCS between 2007 
and 2012 of which 110 could be analysed for this study. In the analysed group 64 
had CD and 46 UC. The characteristics of the whole study population are given in 
table 1. Thirty-one (37.3%) of the children in the CD group and 33 (55.0%) in the UC 
group were female (p = 0.036). The median age of the paediatric CD and UC patients 
was comparable: median CD: 14 years (IQR 12 – 15) and 13.5 (11 – 15) years for 
UC, respectively (p = 0.192) (see table 1). 13.3% of CD patients had ileal 
involvement only (L1 according to the Montreal classification), 13.3% had only 
colonic involvement (L2), 45.8% had ileocoecal inflammation (L3) and 22.9% had 
upper GI involvement (L4) (see table 1).  
With data collected in SIBDCS enrolment questionnaire, we are not be able to make 
the distinction L1/L4a/L4b as in the Paris classification as the study had been 
initiated in 2006 before the Paris classification was published in November 2010. 
Nevertheless, it is possible for further give details on report the disease behaviour for 
CD. B1 disease behaviour (nonstricturing, nonpenetrating) was found 63 (75.9%), B2 
(stricturing only) in 7 (8.4%), B3 (penetrating only) in 10 (12.1%) and B2B3 (both 
stricturing and penetrating) in 3 (3.6%) of our patients (table 1). Perianal disease was 
absent in 58 (69.9%) and present in 25 (30.1%) of the patients. 
In the UC population, 3.3% had proctitis only, 15.0% had left sided colitis and 76.7% 
had pancolitis. This is in accordance with other reports indicating a higher percentage 
of pancolitis in paediatric UC patients [35-39]. Active disease at time of enrolment 
visit (PCDAI > 150 or PUCAI ≥ 10) was noted in 39.5% of patients with CD and 
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37.3% of patients with UC, respectively. Active disease at time of KIDSCREEN 
interview was noted in 35.7% of patients with CD and 28.0% of patients with UC. It 
needs to be mentioned that enrolment questionnaire (physician visit) and 
KIDSCREEN interview were not necessarily carried out at the same time point. 
However, 81/110 KIDSCREEN interview were made within +/- 10 days of enrolment 
visit. The medical therapy of all pediatric CD and UC patients at the time of the 
survey is summarized in table 2. It indicates that 70.0% patients with UC and 24.1% 
of patients with CD were currently treated with 5-ASA (p-value < 0.001). We also 
observed a small statistically not significant difference for Infliximab treatment (19.3% 
in CD vs 8.3% in UC, p-value = 0.068) and for no current therapy at all (3.6% in CD 
vs 11.7% in UC; p-value = 0.062). Use of adalimumab treatment was very rare, as 
well as combination therapies involving immunosuppressants and anti-TNF agents. 
 
HRQoL in the total sample 
In general, children and adolescents with IBD reported a lower score for physical well 
being as compared to their healthy peers (table 3). However, the difference was not 
statistically significant. We did not observe a difference between patients with CD and 
UC. Furthermore, physical well-being seemed not to be affected by history of surgery 
(47.8 ± 12.1 vs 47.7 ± 10.2, p-value = 0.973). In addition, we could not find a 
statistically significant difference between CD patients with purely inflammatory 
behavior (B1 only) and CD patients with more complicated behavior (B2 and/or B3) 
for the mentioned parameters. However, there was a clear trend for a better score (p 
= 0.069) for physical well-being in the children with B1 disease behaviour. The same 
was found for the comparison between CD Patients with and without perianal 
disease. Whereas in general scores were very similar there was a trend for a better 
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score in CD patients without perianal disease for physical well-being (p = 0.099) 
(table 3). It is noteworthy that mental well-being was not affected at all by the disease 
behaviour. Surprisingly also no difference between patients with active disease and 
patients in remission was detected. 
In contrast, surprisingly the mental well-being was found to be significantly higher in 
the IBD patients as compared to healthy controls (IBD patients: 53.4 ± 10.7 vs 
controls: 50.0 ± 10.0, p-value = 0.001). A significant difference could also be found 
with respect to parents/autonomy (54.4 ± 11.7 vs 50.00 ± 10.00, p-value < 0.001),  
which was higher in paediatric IBD patients as compared to healthy controls. We 
found no difference between CD and UC patients with respect to these parameters. 
While parents/autonomy scores were not different between patients free-of-surgery 
and patients with a past surgical procedure, we could observe significant difference 
for the mental well-being score (no surgery: 52.7 ± 10.5 vs surgery 59.6 ± 11.4, p-
value = 0.043). 
For social support in the total cohort, a statistically significant difference again could 
be found between IBD patients and controls (54.8 ± 10.6 vs 50.0 ± 10.0, p-value < 
0.001). There was no difference between CD and UC patients, as well as surgery-
free patients vs patients with a positive surgery history.  
Similar to what we found for parents’ support and social support the values for self-
evaluation of school performance were even higher in the IBD cohort as compared to 
healthy children (53.3 ± 10.4 vs 50.00 ± 10.00, p-value = 0.001). Again this did not 
differ between CD vs UC patients. The history of surgery had no impact on this 
finding. 
Disease duration was not found to be a statistically significant factor for any of the 
KIDSCREEN subscores. We observed a negative association of disease duration 
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with physical well-being and social support, but a positive association with the three 
other subscores, especially mental well-being (Spearman’s rho: 0.133, p-
value=0.168) 
 
Socioeconomic status and HRQoL 
Socioeconomic status, education of the parents and migratory background were 
analysed. Social supports are known to correlate with these factors. Therefore, we 
further analyzed the following socioeconomic factors: mother formation (low vs high), 
father formation (low vs high), mother’s country of birth (Switzerland vs other), 
father’s country of birth (Switzerland vs other), and parent’s country of country (both 
Switzerland vs one Switzerland vs both other). The vast majority of children were 
born in Switzerland, and therefore a comparison for the child birth country was not 
possible. We defined higher education as having university, “technicum”, higher 
professional school. For mothers lower education was reported in 50 cases (66.7%) 
and higherin 25 (33.3%), missing = 40. For fathers the numbers were: Low = 36 
(57.1%), high = 27 (42.9%), missing = 52. The results are given in table 4. Only the 
difference between “No parents born in Switzerland” and “Two parents born in 
Switzrtland” turned out to be statistically significant at 1.7% level (Bonferroni 
correction). 
  
HRQoL in paediatric IBD across the French and German part of Switzerland 
Surprisingly we found a difference for the HRQoL variables between the French and 
German speaking part of Switzerland (table 5). Whereas there was no difference as 
compared to healthy children for physical well-being in the German speaking IBD 
cohort (49.6 ± 11.7, p-value = 0.750 vs control) there was a clear impairment in the 
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French speaking part of Switzerland (40.1 ± 10.0, p-value = < 0.001 vs control). We 
observed that this finding was independent of the diagnosis, detecting the same kind 
of differences when stratifying by disease type, except for French speaking UC 
patients (42.39 ± 10.11, p-value = 0.093), where a sample size of only 7 could play a 
role. 
Whereas the scores for mental well-being were even higher as compared to healthy 
subjects in the German speaking patient group (54.5 ± 10.8, p-value< 0.001 vs control) 
there was a non-significant reduction in mental well-being in the French speaking 
patient group (48.8 ± 9.4, p-value = 0.576 vs control). The same trend was found for 
parents/autonomy (German speaking patient cohort: 55.6 ± 11.0, p < 0.001vs control; 
French speaking patient cohort: 49.4 ± 13.4, p-value = 0.838 vs control) and for social 
support/peers (German speaking patient cohort: 55.9 ± 9.1, p-value < 0.001vs control; 
French speaking patient cohort: 49.8 ± 15.0, p-value= 0.950 vs control). For school 
performance better values were recorded in both sub-cohorts with a significant 
difference only in the German speaking individuals (German speaking patient cohort: 
53.7 ± 10.0, p-value < 0.001vs control; French speaking patient cohort: 51.2 ± 12.0, 
p-value = 0.671 vs control). Again, we found similar differences when taking into 
account disease type separately, with the only exception of school environment for 
German speaking UC patients (52.0 ± 8.7, p-value = 0.162). 
 
Age- and gender-specific HRQoLin paediatric IBD 
Gender-specific results are shown in table 6 and figure 1. Boys with IBD presented a 
lower score for physical well-being than the control population (46.8 ± 10.7 vs 50.0 ± 
10.0, p-value = 0.022), and the four other scores were higher than for the control 
population, however not statistically significant for mental well-being and school 
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environment. Girls with IBD presented a similar pattern, but physical well-being was 
not found to differ significantly from the control population (47.8 ± 12.6 vs 50.0 ± 10.0, 
p-value = 0.224). Nevertheless, when comparing boys with IBD to girls with IBD, we 
found no statistical difference. This finding was independent of the disease type. 
Differences between children (< 12 years old), young adolescents (between 12 and 
14 years old) and old adolescents (> 14 years old) are shown in figure 2 (for 
discrimination of young versus older adolescents see [14, 40,Cotton, 2009 #1019, 
41]). Children systematically report a lower HRQoL as compared to young and old 
adolescents; however the differences are not statistically significant. For children, no 
statistical difference was found among the five subscores compared to control group. 
On the contrary, young and old teenagers showed significantly higher mental, 
parental, social and school scores compared to control group, but physical well being 
was not statistically different from the control group, although lower in mean. 
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Discussion 
The present paper demonstrates in a large cohort of paediatric IBD patients the 
impact of the disease on HRQoL. To our knowledge, this is one of the first studies 
investigating the impact on HRQoL with a generic and internationally valid HRQoL 
instrument. The study provided several surprising results. First, in the KIDSCREEN 
index an only moderate impairment of children with IBD as compared to healthy, age 
matched controls was found for physical well-being. This impairment of physical well-
being may obviously be caused by the activity of the intestinal inflammation and the 
consecutive symptoms of the disease. Second, mental well-being and social support 
were not different or even better than control values, indicating that in contrast to 
other reports depression and emotional impairment are not more abundant in 
paediatric IBD patients of this cohort. Third, autonomy and school variables were 
significantly higher in the paediatric IBD patients in this Swiss cohort.  
The impact of IBD on the physical well-being appeared to be different in the French 
and German speaking part of Switzerland. No simple factors could be identified that 
would easily explain this observed difference. However, even in the French speaking 
part of our cohort no clearly negative impact of IBD on psychological parameters was 
observed. Interestingly in an evaluation of the KIDSCREEN between different 
countries using the self-report version, the highest scores were observed in the 
Netherlands (53.9) and Austria (53.1) and the lowest values in France (46.8) and 
Poland (46.8)[42]. A general trend to a lower score in the French population may well 
contribute to our findings. It would explain why the scores from the French speaking 
paediatric IBD patients are lower (as compared to the average healthy control score). 
It would further support the concept that mental and social HRQoL scores are not 
impaired in the paediatric IBD patients in our cohort. 
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Previous evaluations of the KIDSCREEN score have shown that children aged 8–11 
score higher than adolescents aged 12–18 on the self-report and parent-report 
version[42]. In addition, girls had a trend to slightly lower scores, which was only 
significant in the 8 – 11 years age-group. In our cohort we could not find any 
significant gender difference in any age group. In contrast the numbers were even 
higher (but not significant) for all parameters among the female patients (figure 1). 
In contrast to previous studies we could not find an impaired mental well-being in our 
patients. Engstrom et al. had reported that parents of paediatric IBD patients had 
significantly lower scores on a social support scale[43]. The mental health of the 
children with IBD correlated with the social support[43]. On the other hand Engstrom 
already found that HRQoL in paediatric IBD patients is not only dependent on the 
course of the intestinal inflammation but also on the psychological and social support 
and situation [44]. With respect to those findings we conclude from our data that 
good social support may enable paediatric IBD patients to completely cope with their 
symptoms. This further underlines the importance of social support and good coping 
strategies. There was only a minor impact of the socioeconomic background of the 
patients.  
Our results with respect to the impact of surgery on HRQoL also are in contrast to 
other reports: Casellas and co-workers compared 29 CD patients in remission with 
previous bowel resections to 42 clinically active CD patients and 48 patients with 
medically induced remission with respect to HRQoL measured by Inflammatory 
Bowel Disease Questionnaire (IBDQ), the Psychological General Well Being Index 
(PGWBI), and the EuroQol. They found that both operated and non-operated inactive 
CD patients had lower HRQOL scores than controls[45]. Emotional, social, or 
functional dimensions did not differ significantly between operated and non-operated 
Rogler D. et al.                Excellent HRQoL in Swiss Children with IBD  18 
 
inactive CD patients[45]. They conclude that HRQoL is impaired in active CD, and 
improves during remission irrespective of whether it had been achieved medically or 
surgically[45]. While we also did not detect significant differences for 
parents/autonomy scores between free-of-surgery patients and patients with a past 
surgical procedure, the patients that had undergone surgery had a significantly better 
mental well-being score. 
In line with our findings are studies reporting that steroid exposure, hospitalizations, 
and time from IBD diagnosis do not significantly impact on HRQoL in paediatric 
IBD[46]. 
Our study has strengths and limitations. One strength is the cohort design evaluating 
the health related quality of life in a large proportion of paediatric Swiss IBD patients. 
The quality of the data is robust. A possible limitation may be that a selection bias 
occurred as mainly patients from representative university hospitals and less from 
private practices have been included. However, it can be assumed that paediatric 
patients treated in private practice have less health impairments and that a 
predominance of clinic patients may – if at all – introduce a bias towards more severe 
disease and consecutively more impairment of the health related quality of life.  In 
addition only few children with IBD are cared for in private practice contrary to the 
adult patient with IBD. Another limitation may be the instrument used here, the 
KIDSCREEN index. While most children deny in questionnaires or interviews that 
IBD interferes with their lives, with persistent questioning many admit frustration and 
anger about their IBD symptoms and treatment[14, 47]. Further, the question, 
whether a statistical significant difference in the KIDSCREEN represents a clinically 
important difference is difficult to answer. Indeed many of the scores were quite 
close. 
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In conclusion, our cohort study demonstrates that mental well-being, social support 
as well as school performance are excellent in the paediatric Swiss IBD cohort. 
HRQoL does not necessarily need to be impaired in children with IBD as long as 
coping strategies are effective.   
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Tables 
Table 1          Clinical characteristics of the whole cohort of paediatric patients of the SIBDC. 
Active Disease was defined as PCDAI > 150 for CD and PUCAI >= 10 for 
UC.    
  CD UC p-Value 
Number of patients 83 60 - 
Female 31 (37.3%) 33 (55.0%) 0.036 
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Age: median (IQR)  14 (12 – 15) 13.5 (11 – 15) 0.192 
Age at diagnosis: median 
(IQR) 
11.9 (10 – 13.9) 10.8 (7.1 – 12.7) 0.011 
Disease duration (years): 
median (IQR) 
1.25 (0.7 – 2.2) 2.1 (1.3 – 3.5) 0.002 
CD location : 
L1 (Ileal) 
L2 (Colonic) 
L3 (Ileo-colonic) 
L1 + L4 
L2 + L4 
L3 + L4 
Unknown or unclear 
 
11 (13.3%) 
11 (13.3%) 
38 (45.8%) 
1 (1.2%) 
5 (6.0%) 
13 (15.7%) 
4 (4.8%) 
-  
CD behaviour: 
B1 (nonstricturing, 
nonpenetrating) 
B2 (stricturing only)  
B3 (penetrating only):  
B2B3 (both stricturing 
and penetrating) 
 
 
63 (75.9%) 
7 (8.4%) 
10 (12.1%) 
 
3 (3.6%) 
  
Perianal disease:  
 
No = 58 (69.9%) 
Yes = 25 (30.1%) 
  
UC location 
Proctitis 
Left sided colitis 
Pancolitis 
Unknown or unclear 
-  
2 (3.3%) 
9 (15.0%) 
46 (76.7%) 
3 (5.0%) 
 
PCDAI: median (IQR; 
range) 
10 (5-17.5; 0-40) -  
PUCAI: median (IQR; 
range) 
- 5, (IQR 0-15, 0-60)  
Active disease 17 (39.5%) 
(40 missing) 
22 (37.3%) 
(1 missing) 
0.817 
CD surgery 11 (13.3%) - - 
UC surgery - 1 (1.7%) - 
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Table 2.          Current medication of the pediatric IBD patients  
 
 
 Medication CD  UC  p-Value 
None 3 (3.6%) 7 (11.7%) 0.062 
5-aminosalicylates 20 (24.1%) 42 (70.0%) < 0.001 
Azathioprine/6-MP 50 (60.2%) 29 (48.3%) 0.158 
Infliximab (monotherapy) 16 (19.3%) 5 (8.3%) 0.068 
Adalimumab (monotherapy) 2 (2.4%) 1 (1.7%) 1.000 
Azathioprine+infliximab 2 (2.4%) 1 (1.7%) 1.000 
Azathioprine+adalimumab 2 (2.4%) 0 (0.0%) 0.510 
Methotrexate 10 (12.1%) 7 (11.7%) 0.945 
Antibiotics 2 (2.4%) 0 (0.0%) 0.510 
Others 21 (25.3%) 10 (16.7%) 0.216 
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Table 3.  Values of the KIDSCREEN self report T-scores  
 
 IBD Patients   
Nb Mean Std dev. t-value* p-value* 
Total Cohort 
Physical well-being 110 47.8 11.9 -1.943 0.054 
Mental well-being 110 53.4 10.7 3.323 0.001 
Parents/autonomy 110 54.4 11.7 3.976 < 0.001 
Social support/peers 108 54.8 10.6 4.761 < 0.001 
School 107 53.3 10.4 3.285 0.001 
 
*Ho: mean = 50 (control) 
 CD Patients UC Patients  
Nb Mean Std Dev. Nb Mean Std Dev. p-value** 
  Physical well-being 64 47.3 12.2 46 48.5 11.7 0.594 
  Mental well-being 64 52.7 10.7 46 54.4 10.8 0.420 
  Parents/autonomy 64 54.8 11.8 46 53.9 11.6 0.706 
  Social support/peers 63 54.3 11.2 45 55.6 9.7 0.499 
  School 62 54.0 10.8 45 52.3 9.7 0.424 
 
**Two-sided 
 Patients without surgery 
history 
Patients with surgery 
history 
 
Nb Mean Std Dev. Nb Mean Std Dev. p-value** 
  Physical well-being 99 47.8 12.1 11 47.7 10.2 0.973 
  Mental well-being 99 52.7 10.5 11 59.6 11.4 0.043 
  Parents/autonomy 99 54.2 11.6 11 56.3 13.0 0.569 
  Social support/peers 97 54.5 10.9 11 57.6 6.3 0.368 
  School 97 53.3 10.4 10 53.5 10.4 0.935 
 
**Two-sided 
 
 
 
 
 CD Patients with CD Patients with  
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purely inflammatory 
behavior (B1 only) 
more complicated 
behavior (B2 and/or B3) 
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value** 
  Physical well-being 48 48.9 12.5 16 42.5 10.2 0.069 
  Mental well-being 48 52.1 10.6 16 54.4 11.0 0.466 
  Parents/autonomy 48 55.4 11.4 16 52.9 13.2 0.460 
  Social support/peers 48 54.6 11.8 15 53.2 9.3 0.673 
  School 48 54.1 10.8 14 53.6 11.3 0.872 
**: Two-sided 
 
Comparison of perianal disease vs no perianal disease: 
 
 CD Patients with 
no perianal disease 
CD Patients with 
perianal disease 
 
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value** 
  Physical well-being 46 45.7 12.6 18 51.3 10.3 0.099 
  Mental well-being 46 51.7 11.3 18 55.1 8.7 0.261 
  Parents/autonomy 46 54.8 11.3 18 54.8 13.4 0.997 
  Social support/peers 45 54.2 11.6 18 54.5 10.4 0.928 
  School 44 53.2 9.6 18 55.8 13.5 0.408 
**: Two-sided 
 
 
 Patients in remission Patients with 
active disease 
 
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value** 
  Physical well-being 34 49.6 10.7 16 46.6 15.5 0.431 
  Mental well-being 34 52.6 10.4 16 53.9 14.4 0.712 
  Parents/autonomy 34 54.4 11.7 16 54.9 9.0 0.888 
  Social support/peers 34 53.8 9.7 15 52.1 13.6 0.612 
  School 34 55.1 10.4 15 52.6 10.6 0.456 
**: Two-sided 
 
 
 
 Correlation with Disease Duration 
Nb Spearman’s rho p-value** 
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  Physical well-being 109 -0.007 0.941 
  Mental well-being 109 0.133 0.168 
  Parents/autonomy 109 0.084 0.381 
  Social support/peers 107 -0.111 0.251 
  School 106 0.059 0.544 
 
**Two-sided
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Table 4: Socioeconomic status ans HRQoL 
 
Mother formation: 
 Mother with no higher 
education 
Mother with higher 
education 
 
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value** 
  Physical well-being 50 49.8 11.6 25 42.4 9.7 0.008 
  Mental well-being 50 54.3 9.6 25 50.4 11.6 0.125 
  Parents/autonomy 50 54.5 12.5 25 52.7 11.6 0.541 
  Social 
support/peers 
50 55.1 10.4 23 50.9 9.8 0.113 
  School 50 53.4 10.3 22 53.0 9.1 0.871 
**: Two-sided 
 
 
Father formation 
 Father with no higher 
education 
Father with higher 
education 
 
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value** 
  Physical well-being 36 49.4 12.2 27 42.8 10.2 0.025 
  Mental well-being 36 53.6 10.5 27 50.2 9.7 0.190 
  Parents/autonomy 36 54.5 13.3 27 51.5 11.3 0.356 
  Social 
support/peers 
36 53.6 11.5 25 52.8 10.5 0.778 
  School 36 53.0 10.9 24 52.3 8.5 0.781 
**: Two-sided 
 
Mother’s country of birth: 
 Mother not born in 
Switzerland 
Mother born in Switzerland  
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value** 
  Physical well-being 16 43.1 13.0 63 49.7 12.0 0.054 
  Mental well-being 16 50.6 11.5 63 54.4 10.6 0.206 
  Parents/autonomy 16 54.3 12.3 63 54.7 12.3 0.901 
  Social 
support/peers 
15 52.7 11.0 62 54.5 10.3 0.545 
  School 14 57.8 11.3 62 52.3 9.8 0.070 
**: Two-sided 
 
Father’s country of birth: 
 Father not born in 
Switzerland 
Father born in Switzerland  
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Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value** 
  Physical well-being 24 44.6 12.7 55 50.1 11.9 0.066 
  Mental well-being 24 51.2 12.9 55 54.6 9.8 0.201 
  Parents/autonomy 24 54.4 13.7 55 54.7 11.7 0.921 
  Social 
support/peers 
22 54.4 12.2 55 54.0 9.8 0.864 
  School 21 53.8 11.3 55 53.2 9.9 0.804 
**: Two-sided 
 
 No parent born in 
Switzerland 
One of the two 
parents born in 
Switzerland 
Both parents born 
in Switzerland 
 
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
Nb Mean Std 
Dev. 
p-
value*** 
  Physical well-
being 
12 40.2 12.7 15 50.2 11.5 51 45.8 10.2 0.039 
  Mental well-
being 
12 48.5 11.4 15 55.5 13.2 51 54.5 9.8 0.184 
  
Parents/autonomy 
12 53.5 13.9 15 56.4 12.2 51 54.5 12.0 0.818 
  Social 
support/peers 
11 53.2 12.0 14 54.7 12.1 51 54.2 9.9 0.938 
  School 10 57.7 12.0 14 52.3 10.8 51 52.8 9.8 0.359 
***F-test. 
Two-groups testing for Physical Well-Being: 
 
No parents vs One parent: p-value = 0.041 
No parents vs Two parents: p-value = 0.015 
One parent vs Two parents: p-value = 0.950 
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Table 5. HRQoL in paediatric IBD across the French and German part of Switzerland 
 
 IBD Patients   
Nb Mean Std dev. t-value* p-value* 
German speaking 
Physical well-being 89 49.61 11.66 -0.319 0.750 
Mental well-being 89 54.47 10.75 3.922 < 0.001 
Parents/autonomy 89 55.61 10.98 4.826 < 0.001 
Social support/peers 89 55.91 9.08 6.143 < 0.001 
School 89 53.70 10.01 3.491 < 0.001 
French speaking 
Physical well-being 21 40.10 10.01 -4.531 < 0.001 
Mental well-being 21 48.82 9.44 -0.568 0.576 
Parents/autonomy 21 49.39 13.43 -0.206 0.838 
Social support/peers 19 49.78 15.04 -0.062 0.950 
School 18 51.21 11.97 0.431 0.671 
 
*Ho : mean = 50 (control) 
 
 
 IBD Patients   
Nb Mean Std dev. t-value* p-value* 
German speaking – CD patients 
Physical well-being 50 49.60 11.75 -0.239 0.812 
Mental well-being 50 54.56 10.48 3.073 0.004 
Parents/autonomy 50 56.20 10.88 4.028 < 0.001 
Social support/peers 50 55.64 9.49 4.207 < 0.001 
School 50 55.04 10.83 3.294 0.002 
German speaking – UC patients 
Physical well-being 39 49.60 11.69 -0.209 0.835 
Mental well-being 39 54.36 11.23 2.426 0.020 
Parents/autonomy 39 54.87 11.21 2.716 0.010 
Social support/peers 39 56.26 8.64 4.522 < 0.001 
School 39 51.99 8.70 1.427 0.162 
French speaking – CD patients 
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Physical well-being 14 38.96 10.14 -4.075 0.001 
Mental well-being 14 46.03 8.73 -1.699 0.113 
Parents/autonomy 14 49.76 13.88 -0.065 0.949 
Social support/peers 13 48.89 15.47 -0.258 0.801 
School 12 49.51 10.12 -0.169 0.869 
French speaking – UC patients 
Physical well-being 7 42.39 10.11 -1.992 0.093 
Mental well-being 7 54.41 8.83 1.322 0.234 
Parents/autonomy 7 48.67 13.54 -0.260 0.804 
Social support/peers 6 51.71 15.29 0.274 0.794 
School 6 54.64 15.53 0.731 0.497 
*Ho : mean = 50 (control) 
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Table 6. Age- and gender-specific HRQoL in paediatric IBD of the SIBDCS 
 
 IBD Patients   
Nb Mean Std dev. t-value* p-value* 
Boys 
Physical well-being 62 46.79 10.74 -2.353 0.022 
Mental well-being 62 52.31 10.55 1.727 0.089 
Parents/autonomy 62 53.30 10.95 2.371 0.021 
Social support/peers 60 53.29 10.07 2.529 0.014 
School 60 51.68 9.70 1.339 0.186 
Girls 
Physical well-being 48 47.75 12.64 -1.232 0.224 
Mental well-being 48 53.20 10.52 2.107 0.041 
Parents/autonomy 48 54.36 11.77 2.566 0.014 
Social support/peers 48 55.97 10.69 3.872 < 0.001 
School 47 52.80 9.73 1.970 0.055 
 
*Ho: mean = 50 (control) 
 
 
 Boys Girls  
Nb Mean Std Dev. Nb Mean Std Dev. p-value** 
Total cohort 
  Physical well-being 62 46.79 10.74 48 47.75 12.64 0.668 
  Mental well-being 62 52.31 10.55 48 53.20 10.52 0.663 
  Parents/autonomy 62 53.30 10.95 48 54.36 11.77 0.626 
  Social support/peers 60 53.29 10.07 48 55.97 10.69 0.183 
  School 60 51.68 9.70 47 52.80 9.73 0.555 
CD Patients 
  Physical well-being 41 46.66 11.40 23 45.58 11.86 0.722 
  Mental well-being 41 51.39 10.67 23 52.24 9.41 0.743 
  Parents/autonomy 41 52.26 10.22 23 56.50 11.72 0.154 
  Social support/peers 40 52.51 10.71 23 55.96 11.17 0.238 
  School 40 50.99 9.42 22 55.07 10.61 0.139 
UC Patients 
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  Physical well-being 21 47.05 9.56 25 49.74 13.25 0.441 
  Mental well-being 21 54.11 10.33 25 54.07 11.57 0.992 
  Parents/autonomy 21 55.33 12.26 25 52.40 11.70 0.413 
  Social support/peers 20 54.84 8.70 25 55.99 10.45 0.689 
  School 20 53.04 10.34 25 50.79 8.60 0.441 
 
**Two-sided 
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Figure legends 
 
 
Fig.1: Mean scores and 95% confidence intervals according to gender. The red 
horizontal line represents controls score. 
 
 
Fig.2: Mean scores and 95% confidence intervals according to age category. The red 
horizontal line represents controls score.
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